Last reviewed · How we verify
NCT05788887: LadotyriCT
Investigation of the Postprandial Response of Two Different PDO Cheeses on Metabolic Biomarkers
NA trial testing Authentic Ladotyri Mytilinis PDO cheese in Healthy in 10 participants. Completed in 17 January 2022.
17 January 2022
Quick facts
| Lead sponsor | University of the Aegean |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | other |
| Enrollment | 10 |
| Start date | 10 January 2022 |
| Primary completion | 17 January 2022 |
| Estimated completion | 17 January 2022 |
| Sites | 1 location across Greece |
Drugs / interventions tested
- Authentic Ladotyri Mytilinis PDO cheese
- Control
Conditions studied
- Healthy — all drugs for Healthy →
Sponsor
University of the Aegean
Who can join
Adults 18 to 65, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study was the investigation of the postprandial metabolic responses, after the intake of a traditional, Ladotyri Mytilinis cheese, compared to corresponding responses after an Italian Parmesan cheese consumption, in healthy participants.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Postprandial Inflammatory and Metabolic Responses Induced by Authentic Mytilinis Cheese: A Preliminary, Crossover, Nutritional Intervention in Healthy Adults.
Papagianni O, Voutsa A, Katira O, Potsaki P, et al · · 2023 · cited 1× · PMID 37109453 · DOI 10.3390/life13040923
Verify or expand the search:
- PubMed search for NCT05788887
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other University of the Aegean trials
Trials by the same sponsor.
- NCT06983145 — Postprandial Effect of Olive Leaf Biscuits and Tea Consumption on Blood Biomarkers in Healthy Individuals · NA · active not recruiting
- NCT06293859 — Effect of 12-week Probiotic Consumption Immobilized on Oat Flakes on Blood and Urine Biomarkers and Human Microbiome · NA · completed
- NCT05977543 — Acute Effect of Functional Crackers on Postprandial Metabolism · NA · unknown
- NCT05771571 — Investigation of the Acute Effect of Novel Olive Oil on Postprandial Oxidative Stress Biomarkers (BioliveCT) · NA · completed
- NCT06135831 — Effect of Consumption of Supplements and Enriched Olive Paste on Bone Metabolism Indices · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05788887 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of the Aegean
- Last refreshed: 14 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05788887.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing